Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GRETEL TRULLENQUE

Allopathic & Osteopathic Physicians Family Medicine

NPI
1720076144
CMS profile
32746
Location
MIAMI, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$1,374.49

69 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,374.49 69

By paying entity

PY2019 · entire year · sorted by reported total

Page 1 of 2; records 1–50 of 69 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

GRETEL TRULLENQUE

NPI 1720076144 · CMS profile ID 32746

Allopathic & Osteopathic Physicians / Family Medicine

MIAMI, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 69 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1720076144?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
GRETEL TRULLENQUE, NPI 1720076144, CMS profile ID 32746. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 69 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1720076144?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). GRETEL TRULLENQUE, NPI 1720076144, CMS profile ID 32746. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 69 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1720076144?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
GRETEL TRULLENQUE, NPI 1720076144, CMS profile ID 32746, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 69 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1720076144?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

69 matching records · $1,374.49 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 69 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 69.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Scilex Pharmaceuticals Inc. $18.7912/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 689489137 CMS
Merck Sharp & Dohme Corporation $15.9512/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695870345 CMS
SANOFI-AVENTIS U.S. LLC $20.5112/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694294127 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.1312/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700380031 CMS
Scilex Pharmaceuticals Inc. $13.7111/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 689487863 CMS
Kowa Pharmaceuticals America, Inc. $17.2311/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 630305751 CMS
PFIZER INC. $19.1211/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673742619 CMS
AstraZeneca Pharmaceuticals LP $23.1011/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686006437 CMS
AstraZeneca Pharmaceuticals LP $22.9511/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685624333 CMS
Novo Nordisk Inc $18.4411/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 674673423 CMS
ViiV Healthcare Company $18.3011/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671584281 CMS
PFIZER INC. $18.6011/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673719577 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.5310/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700380033 CMS
Merck Sharp & Dohme Corporation $15.6510/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695820287 CMS
Novartis Pharmaceuticals Corporation $16.9310/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660033759 CMS
Ethicon US, LLC $24.5709/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 648698613 CMS
AstraZeneca Pharmaceuticals LP $22.5909/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685236971 CMS
PFIZER INC. $23.8909/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672814537 CMS
Novo Nordisk Inc $15.8809/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 674569627 CMS
PFIZER INC. $16.8109/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672810062 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.9409/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700380035 CMS
Novo Nordisk Inc $19.0709/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 674569625 CMS
AstraZeneca Pharmaceuticals LP $22.5908/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685973349 CMS
Janssen Pharmaceuticals, Inc $14.4008/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659346739 CMS
Lilly USA, LLC $15.3808/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657841003 CMS
Amarin Pharma Inc. $17.8908/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699198241 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.2008/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700380037 CMS
Amneal Pharmaceuticals LLC $17.4107/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 692327289 CMS
Scilex Pharmaceuticals Inc. $17.4807/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 689478957 CMS
GlaxoSmithKline, LLC. $15.6107/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670956385 CMS
Novo Nordisk Inc $23.5907/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 674498591 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.8007/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700380039 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.8306/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684961995 CMS
Merck Sharp & Dohme Corporation $19.3206/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695629509 CMS
Novartis Pharmaceuticals Corporation $16.8506/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660033757 CMS
PFIZER INC. $19.2406/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672096789 CMS
Novo Nordisk Inc $19.4406/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 674460497 CMS
PFIZER INC. $25.9006/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672051065 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.2506/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700380041 CMS
Merck Sharp & Dohme Corporation $19.2405/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695542397 CMS
Galderma Laboratories, L.P. $91.1405/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 687723717 CMS
AstraZeneca Pharmaceuticals LP $22.8205/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685899355 CMS
Novartis Pharmaceuticals Corporation $16.8505/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660033753 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.2905/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700380043 CMS
PFIZER INC. $16.2105/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672053721 CMS
AstraZeneca Pharmaceuticals LP $22.8204/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685353955 CMS
Lilly USA, LLC $14.6504/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657854541 CMS
Janssen Pharmaceuticals, Inc $16.3704/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659346737 CMS
PFIZER INC. $24.5604/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671977367 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.5404/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684961993 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,374.49 69
PY2020 $1,355.75 79
PY2021 $259.48 14
PY2022 $192.27 9
PY2023 $2,004.82 9
PY2024 $1,983.09 17
PY2025 $1,220.64 5

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $1,629,687.56 10
PY2024 Principal investigator $1,001,480.43 22
PY2023 Principal investigator $393,727.30 31
PY2022 Principal investigator $743,619.78 33
PY2021 Principal investigator $102,847.74 117
PY2020 Principal investigator $1,098,095.92 216
PY2019 Principal investigator $335,867.48 106

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

106 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 12/17/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629171993
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 12/17/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629176749
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 12/17/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629176931
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 12/16/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629166903
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 12/16/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629167181
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 12/16/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629172455
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 12/16/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629177617
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 12/16/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629178733
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 12/16/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629179029
Principal investigator 1 AbbVie, Inc. $1,221.50 12/11/2019 Non-covered Recipient Entity
Floridian Research Institute, LLC
M16-100 No dispute reported 06/30/2026 647587811
Principal investigator 1 Incyte Corporation $45.60 12/09/2019 Non-covered Recipient Entity
FLORIDIAN RESEARCH INSTITUTE LLC
An Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis No dispute reported 06/30/2026 666518425
Principal investigator 1 Incyte Corporation $2.64 12/09/2019 Non-covered Recipient Entity
FLORIDIAN RESEARCH INSTITUTE LLC
An Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis No dispute reported 06/30/2026 666518427
Principal investigator 1 Incyte Corporation $7.20 12/09/2019 Non-covered Recipient Entity
FLORIDIAN RESEARCH INSTITUTE LLC
An Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis No dispute reported 06/30/2026 666518429
Principal investigator 1 Incyte Corporation $35.79 12/09/2019 Non-covered Recipient Entity
FLORIDIAN RESEARCH INSTITUTE LLC
An Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis No dispute reported 06/30/2026 666518431
Principal investigator 1 Incyte Corporation $67.08 12/09/2019 Non-covered Recipient Entity
FLORIDIAN RESEARCH INSTITUTE LLC
An Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis No dispute reported 06/30/2026 666518433
Principal investigator 1 Incyte Corporation $19.38 12/09/2019 Non-covered Recipient Entity
FLORIDIAN RESEARCH INSTITUTE LLC
An Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis No dispute reported 06/30/2026 666518435
Principal investigator 1 Incyte Corporation $3.80 12/09/2019 Non-covered Recipient Entity
FLORIDIAN RESEARCH INSTITUTE LLC
An Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis No dispute reported 06/30/2026 666518437
Principal investigator 1 Incyte Corporation $31.48 12/09/2019 Non-covered Recipient Entity
FLORIDIAN RESEARCH INSTITUTE LLC
An Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis No dispute reported 06/30/2026 666518439
Principal investigator 1 Incyte Corporation $20.62 12/09/2019 Non-covered Recipient Entity
FLORIDIAN RESEARCH INSTITUTE LLC
An Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis No dispute reported 06/30/2026 666518441
Principal investigator 1 Incyte Corporation $30.40 12/09/2019 Non-covered Recipient Entity
FLORIDIAN RESEARCH INSTITUTE LLC
An Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis No dispute reported 06/30/2026 666518443
Principal investigator 1 Incyte Corporation $13.60 12/09/2019 Non-covered Recipient Entity
FLORIDIAN RESEARCH INSTITUTE LLC
An Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis No dispute reported 06/30/2026 666518445
Principal investigator 1 Incyte Corporation $3.95 12/09/2019 Non-covered Recipient Entity
FLORIDIAN RESEARCH INSTITUTE LLC
An Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis No dispute reported 06/30/2026 666518447
Principal investigator 1 Incyte Corporation $35.10 12/09/2019 Non-covered Recipient Entity
FLORIDIAN RESEARCH INSTITUTE LLC
An Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis No dispute reported 06/30/2026 666518449
Principal investigator 1 Incyte Corporation $45.60 12/09/2019 Non-covered Recipient Entity
FLORIDIAN RESEARCH INSTITUTE LLC
An Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis No dispute reported 06/30/2026 666518451
Principal investigator 1 Incyte Corporation $45.60 12/09/2019 Non-covered Recipient Entity
FLORIDIAN RESEARCH INSTITUTE LLC
An Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis No dispute reported 06/30/2026 666518453
Principal investigator 1 Incyte Corporation $35.10 12/09/2019 Non-covered Recipient Entity
FLORIDIAN RESEARCH INSTITUTE LLC
An Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis No dispute reported 06/30/2026 666518455
Principal investigator 1 AbbVie, Inc. $5,670.30 11/27/2019 Non-covered Recipient Entity
Floridian Research Institute, LLC
M16-100 No dispute reported 06/30/2026 647587813
Principal investigator 1 CIPLA USA INC. $300.00 11/27/2019 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
U-FS-MU-AS3120 No dispute reported 06/30/2026 694712631
Principal investigator 1 CIPLA USA INC. $10,368.44 11/05/2019 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
U-FS-MU-AS3120 No dispute reported 06/30/2026 694712637
Principal investigator 1 AbbVie, Inc. $10,067.60 10/30/2019 Non-covered Recipient Entity
Floridian Research Institute, LLC
M16-100 No dispute reported 06/30/2026 647587809
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 10/24/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629163949
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,994.00 10/24/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629171761
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 10/24/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629173781
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 10/24/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629174207
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 10/24/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629174823
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 10/24/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629176377
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 10/23/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629162709
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,994.00 10/23/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629164257
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 10/23/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629169297
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 10/23/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629171047
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 10/23/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629171287
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 10/23/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629176563
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 10/23/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629177781
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,258.00 10/23/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629177943
Principal investigator 1 AbbVie, Inc. $49.40 09/30/2019 Non-covered Recipient Entity
Floridian Research Institute, LLC
M16-100 No dispute reported 06/30/2026 647587807
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,994.00 09/11/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629178105
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $59,717.00 09/05/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629166055
Principal investigator 1 AbbVie, Inc. $4,878.80 08/29/2019 Non-covered Recipient Entity
Floridian Research Institute, LLC
M16-100 No dispute reported 06/30/2026 647587805
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $45,955.00 08/09/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629177109
Principal investigator 1 CIPLA USA INC. $10.00 07/30/2019 Non-covered Recipient Entity
FLORIDIAN RESEARCH INSTITUTE
U-FS-MU-AS3120 No dispute reported 06/30/2026 694715307
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 07/19/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629174623
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 07/19/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629177451
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 07/18/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629170559
Principal investigator 1 AbbVie, Inc. $16,916.30 07/15/2019 Non-covered Recipient Entity
Floridian Research Institute, LLC
M16-100 No dispute reported 06/30/2026 647587803
Principal investigator 1 AbbVie, Inc. $16,451.60 06/20/2019 Non-covered Recipient Entity
Floridian Research Institute, LLC
M16-100 No dispute reported 06/30/2026 647587801
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 06/11/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629175023
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 06/11/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629175999
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 06/07/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629165465
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 06/07/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629170315
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 06/07/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629173127
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 06/07/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629178267
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 06/07/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629178427
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 05/21/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629163021
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,496.00 05/21/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629168253
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,496.00 05/21/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629169555
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 05/21/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629175223
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 05/17/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629168515
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 05/17/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629175417
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 05/17/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629178583
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 05/17/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629179467
Principal investigator 1 AbbVie, Inc. $13,291.90 05/16/2019 Non-covered Recipient Entity
Floridian Research Institute, LLC
M16-100 No dispute reported 06/30/2026 647587799
Principal investigator 1 Romark Laboratories, LC $25,000.00 05/13/2019 Non-covered Recipient Entity
Florida Research Institute, LLC
Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection No dispute reported 06/30/2026 686156101
Principal investigator 1 AbbVie, Inc. $31,175.30 04/16/2019 Non-covered Recipient Entity
Floridian Research Institute, LLC
M16-100 No dispute reported 06/30/2026 647587797
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,496.00 04/11/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629173347
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 04/11/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629179321
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,496.00 04/04/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629164865
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 04/04/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629166621
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,496.00 04/04/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629172683
Principal investigator 1 AbbVie, Inc. $4,630.40 03/22/2019 Non-covered Recipient Entity
Floridian Research Institute, LLC
M16-100 No dispute reported 06/30/2026 647587795
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,500.00 03/12/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629164563
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,496.00 03/12/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629165761
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 03/12/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629168777
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,496.00 03/12/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629169811
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,496.00 03/12/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629172223
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,496.00 03/12/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629176189
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,496.00 02/27/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629163639
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,496.00 02/27/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629165165
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,496.00 02/27/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629170067
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,496.00 02/27/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629173995
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,496.00 02/27/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629179175
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 02/26/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629167723
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,496.00 02/26/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629172905
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 01/11/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629163329
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 01/11/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629166339
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 01/11/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629167455
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 01/11/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629167989
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,021.00 01/11/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629169037
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 01/11/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629170805
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 01/11/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629171525
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 01/11/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629173565
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,021.00 01/11/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629174415
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,496.00 01/11/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629175611
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 01/11/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629175807
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $943.00 01/11/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY 94-8862 ph 3 conventional in diab nephropathy No dispute reported 06/30/2026 629177283
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,496.00 01/11/2019 Non-covered Recipient Entity
Floridian Research Institute Llc
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629178883
Principal investigator 1 GlaxoSmithKline, LLC. $1,000.00 01/09/2019 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
POST-AUTHORISATION SAFETY (PAS) OBSERVATIONAL COHORT STUDY TO QUANTIFY No dispute reported 06/30/2026 669958463